Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy-Reference-Cited by-同舟云学术

Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy

Published:2018-07-23 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Hijano Diego R.^ORCID,Siefker David T.,Shrestha Bishwas,Jaligama Sridhar,Vu Luan D.,Tillman Heather^ORCID,Finkelstein David,Saravia Jordy,You Dahui,Cormier Stephania A.

Funder

The Institute for Research, Innovation, Synergy and Health Equity at the University of Tennessee

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-29456-w.pdf

Reference57 articles.

1. Hall, C. B., Simoes, E. A. & Anderson, L. J. Clinical and epidemiologic features of respiratory syncytial virus. Current topics in microbiology and immunology 372, 39–57, https://doi.org/10.1007/978-3-642-38919-1_2 (2013).

2. Hall, C. B. et al. The burden of respiratory syncytial virus infection in young children. The New England journal of medicine 360, 588–598, https://doi.org/10.1056/NEJMoa0804877 (2009).

3. Nair, H. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (London, England) 375, 1545–1555, https://doi.org/10.1016/s0140-6736(10)60206-1 (2010).

4. Stein, R. T. et al. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatric pulmonology. https://doi.org/10.1002/ppul.23570 (2016).

5. Wang, E. E., Law, B. J. & Stephens, D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. The Journal of pediatrics 126, 212–219 (1995).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the development of a promising mucosal adjuvant vaccine for human respiratory syncytial virus (RSV) infection;Journal of King Saud University - Science;2024-09

2. Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers;Infectious Diseases and Therapy;2024-08-04

3. Respiratory Virus-Induced PARP1 Alters DC Metabolism and Antiviral Immunity Inducing Pulmonary Immunopathology;Viruses;2024-06-04

4. Development of innate and adaptive immunity to RSV in young children;Cellular Immunology;2024-05

5. Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses;Antiviral Research;2024-03